Chunli Medical has announced the repurchase report of the company's shares through centralized bidding trading, intending to repurchase shares for the purpose of implementing employee shareholding plan or stock-based incentive plan. The intended repurchase scale is 20 to 40 million yuan. The intended repurchase price is no more than 28.56 yuan per share. The intended repurchase period is within 12 months from the date when the company's board of directors approves the share repurchase plan.
春立医疗：拟以2000万元-4000万元回购股份
Chunli Medical: plans to repurchase shares for 20-40 million yuan.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.